Patent Assignment
Reel/Frame 047523/0420
Merger
Recorded: 2018-11-16
Pages: 11
Assignor
COVIS PHARMA S.A R.L.
Executed: 2016-12-30
Assignee
COVIS PHARMA B.V.
OUDE UTRECHTSEWEG 32, 3743 KN, BAARN, NETHERLANDS
Covered Properties
(5)
Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction
Patent:
6,245,791 →
Application:
09/631,798 →
Combination of riluzole and of gabapentin and its use as a medicament
Patent:
6,350,768 →
Application:
09/718,543 →
Riluzole and Alpha-Tocopherol Combination
Use of Riluzole in the Treating Acoustic Traumas
Use of Thiazolobenzoheterocycles for Treating Multiple Sclerosis
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Patent Security Interest
Apr 21, 2015
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: COVIS PHARMA S.A.R.L.; COVIS PHARMA HOLDINGS S.A.R. L.
Reel/Frame 035475/0336 →
Security Interest
Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Security Interest
Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
Release of Security Interest
Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement
Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Security Interest
Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →